Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity

Biotechnology and Bioengineering
Naoko Yamane-OhnukiMitsuo Satoh

Abstract

To generate industrially applicable new host cell lines for antibody production with optimizing antibody-dependent cellular cytotoxicity (ADCC) we disrupted both FUT8 alleles in a Chinese hamster ovary (CHO)/DG44 cell line by sequential homologous recombination. FUT8 encodes an alpha-1,6-fucosyltransferase that catalyzes the transfer of fucose from GDP-fucose to N-acetylglucosamine (GlcNAc) in an alpha-1,6 linkage. FUT8(-/-) cell lines have morphology and growth kinetics similar to those of the parent, and produce completely defucosylated recombinant antibodies. FUT8(-/-)-produced chimeric anti-CD20 IgG1 shows the same level of antigen-binding activity and complement-dependent cytotoxicity (CDC) as the FUT8(+/+)-produced, comparable antibody, Rituxan. In contrast, FUT8(-/-)-produced anti-CD20 IgG1 strongly binds to human Fcgamma-receptor IIIa (FcgammaRIIIa) and dramatically enhances ADCC to approximately 100-fold that of Rituxan. Our results demonstrate that FUT8(-/-) cells are ideal host cell lines to stably produce completely defucosylated high-ADCC antibodies with fixed quality and efficacy for therapeutic use.

References

Mar 1, 1992·Analytical Biochemistry·R Ramírez-SolisA Bradley
Nov 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S L Pennington, J H Wilson
Mar 8, 1990·Nature·H Zheng, J H Wilson
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G A PeltzK W Moore
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J M Sedivy, P A Sharp
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G M AdairJ B Scheerer
Nov 1, 1986·Somatic Cell and Molecular Genetics·G UrlaubJ Hamlin
Jan 1, 1995·Molecular and Cellular Biology·K D Hanson, J M Sedivy
Oct 1, 1994·Molecular and Cellular Biology·J B Scheerer, G M Adair
Jan 1, 1993·Plant Physiology·K Nakamura, K Matsuoka
Nov 5, 1997·International Journal of Cancer. Journal International Du Cancer·E MiyoshiN Taniguchi
Feb 10, 1998·International Journal of Cancer. Journal International Du Cancer·K NodaN Taniguchi
Oct 2, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K NodaM Yoshikawa
Nov 18, 1998·Current Opinion in Oncology·G A Leget, M S Czuczman
Dec 2, 1999·Biochimica Et Biophysica Acta·E MiyoshiN Taniguchi
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Jul 21, 2000·DNA Sequence : the Journal of DNA Sequencing and Mapping·H HayashiT Imamura
Nov 28, 2000·International Journal of Cancer. Journal International Du Cancer·T TakahashiN Taniguchi
Apr 5, 2001·Current Opinion in Biotechnology·L Chu, D K Robinson
Apr 12, 2001·The Journal of Biological Chemistry·S RadaevP D Sun

❮ Previous
Next ❯

Citations

Apr 28, 2010·Applied Microbiology and Biotechnology·Chung-Jr HuangCarl A Batt
Aug 7, 2010·Applied Microbiology and Biotechnology·Oliver KrämerThomas Noll
Oct 12, 2012·Applied Microbiology and Biotechnology·M Butler, A Meneses-Acosta
Aug 7, 2009·Cancer Immunology, Immunotherapy : CII·Pina M CardarelliDavid J King
Nov 13, 2008·Cytotechnology·Niall BarronMohan Muniyappa
Nov 13, 2008·Cytotechnology·Makiko YamashitaSanetaka Shirahata
Jul 4, 2012·Journal of the American Chemical Society·Wei HuangLai-Xi Wang
Aug 10, 2010·Acta Pharmacologica Sinica·Jing Li, Zhenping Zhu
Mar 12, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yunxiang ZhuSeng H Cheng
Oct 13, 2006·Nature Biotechnology·Gary Walsh, Roy Jefferis
Dec 11, 2007·Nature Biotechnology·Wayne A Marasco, Jianhua Sui
Feb 28, 2009·Nature Reviews. Drug Discovery·Roy Jefferis
Mar 31, 2012·Nature Reviews. Drug Discovery·P Mark Hogarth, Geoffrey A Pietersz
Mar 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yolanda SantiagoTrevor N Collingwood
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Stephen L SazinskyK Dane Wittrup
May 30, 2009·The Journal of Biological Chemistry·Richard StrasserHerta Steinkellner
Jun 6, 2009·Glycobiology·Patrick HosslerZheng Jian Li
Sep 21, 2011·Glycobiology·Michiko N Fukuda
Mar 15, 2006·Journal of Immunotherapy·Karin BarbinGeorg H Fey
Jun 27, 2006·Journal of Immunotherapy·Bernard J ScallonMarian T Nakada
Oct 13, 2012·Anti-cancer Drugs·Jay J ListinskyCatherine M Listinsky
Sep 2, 2009·Biological & Pharmaceutical Bulletin·Setsuko TojoToshiyuki Suzawa
Jan 5, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kunihiko Itoh
Jan 6, 2009·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kenya Shitara
Aug 9, 2007·PloS One·Patrick HosslerWei-Shou Hu
Nov 19, 2009·Drug Design, Development and Therapy·Akito NatsumeMitsuo Satoh
Nov 3, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Etsuji Kaneko, Rinpei Niwa
May 22, 2013·International Journal of Cell Biology·Xiaotian Zhong, Jill F Wright
May 28, 2014·Glycobiology·Catharina SteentoftHenrik Clausen
Apr 23, 2014·Proceedings of the National Academy of Sciences of the United States of America·Beatriz TrastoyEric J Sundberg
Apr 30, 2011·Chinese Journal of Cancer·Zhenping Zhu, Li Yan
Nov 17, 2009·Current Opinion in Allergy and Clinical Immunology·Stephen T Holgate
Jul 16, 2015·Expert Opinion on Biological Therapy·Martina Dicker, Richard Strasser
Oct 20, 2006·Expert Opinion on Biological Therapy·Mitsuo SatohKenya Shitara
Aug 31, 2007·Expert Opinion on Biological Therapy·Roy Jefferis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.